By Editor , 31 October 2026
POLYTECH and LRI Launch Global Adipose Tissue Partnership
POLYTECH and LRI Launch Global Adipose Tissue Partnership

DIEBURG – October 30, 2026 -- POLYTECH Health & Aesthetics, which operates in more than 90 countries, and the London Regenerative Institute (LRI) have formed a worldwide partnership to advance adipose tissue-based techniques in aesthetic and reconstructive surgery.

Partnership pairs POLYTECH's global reach with LRI's processing know-how

POLYTECH contributes an international commercial infrastructure, long-standing relationships with plastic and reconstructive surgeons, and a hands-on training model. LRI, a clinician-led institute, contributes research and development in adipose tissue processing, regenerative protocols and structured clinical training.

The companies say fat grafting is increasingly used beyond traditional volume restoration, including refinement procedures and applications focused on tissue quality and regeneration. They add that the techniques are gaining importance in both surgical and office-based settings.

LRI's LipoCube ecosystem covers standard grafting to nanofat preparation

LRI has built an ecosystem around adipose tissue applications, including LipoCube and related technologies for different levels of tissue processing. These range from standard fat grafting to micro- and nanofat preparation and biologically oriented adjuncts. The institute also runs training programs and workshops intended to move these techniques into routine clinical use.

Training programs form the core of the rollout

The partnership centers on workshops, physician education and procedure-oriented guidance. The companies state that outcomes depend not only on the technology used but also on the consistency of preparation and application.

LRI founder Prof. Dr. Tunç Tiryaki identified the standardization of tissue processing and clinical workflows as a major challenge in regenerative surgery. POLYTECH CEO Prof. Dr. Karsten Hemmrich said the alliance combines scientific expertise, clinical education and global commercial reach to give surgeons structured, reproducible approaches.

The partnership involves launching a portfolio alongside physician education initiatives, workshops and clinical training programs. Details on market rollout, training activities and product availability will follow in line with local regulatory requirements.

News Type
Target market(s)
Products
Editorial Review Status
Auto-passed (DeepSeek Low Risk)